Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink implanted its first brain chip in a human, marking a significant milestone in human-computer interaction. This implant allows users to control devices with their thoughts, with potential future applications in curing blindness and neuron damage.
A close rival, Synchron, has just announced an innovative use of its BCI system, enabling a patient with ALS to control the Apple Vision Pro using only brain signals. This breakthrough allows for hands-free and voice-free interaction, enhancing accessibility for those with severe motor impairments. The Synchron BCI, implanted through a minimally invasive procedure, detects and transmits motor intent from the brain to control digital interfaces (Med Xpress).
But here, I decided to summarize some lesser-known emerging players in the neurotech space, which are developing intriguing technologies worth keeping an eye on.
Founded by Dan Furman and Eitan Kay in Los Angeles, California, Arctop develops software that uses artificial intelligence to analyze brain activity. Arctop's tools aim to translate feelings, reactions, and intent, optimizing skill training and enabling new forms of communication.
US-based Diagnostic Biochips, founded by Dr. Brian Jamieson, a former NASA engineer is empowering neuroscientists to conduct advanced electrophysiology research aimed at curing complex neurological diseases such as Parkinson’s and epilepsy. Utilizing patented technologies, including a microfabricated implantable neurosensor and data analysis software, the company provides high-fidelity brain data with exceptional spatiotemporal resolution.
Based in Boston and founded by Ramses Alcaide, Neurable aims to eliminate limitations by creating technology that enables control of computers using brain signals. Their brain-computer interface allows users to interact with software and devices solely through brain activity.
The company has raised $13M in its latest funding round.
Continue reading
This content available exclusively for BPT Mebmers
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
